SMARCA4 and neoplasm: However, none of the previously developed Group 3 MB mouse models include alterations of Smarca4. In this study, we present a new MB mouse model with combined MYC overexpression and SMARCA4 loss in granule cell precursors (GCPs) and provide evidence for a tumor-promoting role of a SMARCA4 deficiency in MB.